An in vitro comparison of cold atmospheric plasma and methylene blue-mediated antimicrobial photodynamic therapy with 660 nm laser on Streptococcus mutans biofilms Authors: Mohammad Amin Arastouei, Arash Azizi, Mohammad Vahedi, Maryam Pourhajibagher Published: 2026 ABSTRACT This study aimed to comparatively evaluate the antimicrobial and antibiofilm efficacy of helium-based cold atmospheric plasma (CAP) and methylene blue–mediated antimicrobial photodynamic therapy (MB-aPDT) against mature Streptococcus mutans biofilms formed on human enamel surfaces. In this study, standardized enamel slabs prepared from extracted human premolars were inoculated with S. mutans ATCC 35,668 and incubated for 7 days to allow mature biofilm formation in the presence of sucrose and human saliva. Specimens were randomly allocated to nine experimental groups (n = 10): negative control, 0.2% chlorhexidine (CHX), laser only (660 nm, 100 mW, 20 J/cm², 100 s), 0.02% methylene blue (MB) only, MB-aPDT (0.02% MB + 660 nm laser), and CAP applied for 90, 120, 150, and 180 s. Quantitative assessment of biofilm viability was performed by colony-forming unit (CFU/mL) counting. Structural alterations were qualitatively analyzed using scanning electron microscopy (SEM). Data were analyzed using one-way ANOVA and Tukey post hoc tests (α = 0.05). Both MB-aPDT and CAP significantly reduced S. mutans biofilm viability compared with the untreated control (p < 0.001). MB-aPDT achieved a 90.7% reduction in CFU counts. CAP demonstrated a time-dependent antibacterial effect, with progressive reductions from 53.5% at 90 s to 87.0% at 180 s. MB-aPDT was significantly more effective than CAP at 90, 120, and 150 s (p < 0.001), whereas no significant difference was observed between MB-aPDT and CAP at 180 s (p = 0.266). SEM analysis corroborated quantitative findings, revealing marked disruption of biofilm architecture following MB-aPDT and CAP-180 s treatments. Both MB-aPDT and helium-based CAP exhibit significant antibiofilm activity against mature S. mutans biofilms on enamel surfaces. While MB-aPDT demonstrated superior efficacy compared with shorter CAP exposures, prolonged CAP treatment achieved comparable antibacterial effects. These findings support the potential integration of both modalities as adjunctive, minimally invasive strategies for biofilm control in preventive and restorative dentistry. Introduction Dental caries persists as a globally prevalent and economically burdensome chronic disease, exerting substantial pressure on healthcare infrastructures worldwide [1]. The pathogenesis of caries is intrinsically linked to ecological imbalances within the dental plaque biofilm—a dynamic, polymicrobial consortium adhered to the tooth surface [2]. Within this complex ecosystem, Streptococcus mutans is established as a principal cariogenic pathogen. Its pathogenicity is due to three key features: proficient adhesion to the pellicle-coating enamel, robust synthesis of extracellular polymeric substances (EPS) that scaffold the biofilm architecture, and vigorous fermentation of dietary sugars into organic acids. This concerted acidogenic and aciduric metabolism drives localized enamel demineralization, thereby initiating the carious process [3]. Consequently, the effective management of cariogenic biofilms, especially those with significant S. mutans bioburden, is a critical objective in preventive and therapeutic dentistry [4]. Conventional caries management primarily relies on mechanical disruption and removal of dental biofilms through personal oral hygiene measures and professional debridement. However, the effectiveness of these approaches is often limited by inadequate patient compliance, restricted access to dental care, and the persistence of microorganisms within anatomically protected sites such as deep pits, fissures, and dentinal tubules [5]. Although adjunctive antiseptic agents, particularly chlorhexidine, demonstrate substantial antimicrobial efficacy against oral biofilms, their prolonged use has been associated with several undesirable effects, including tooth discoloration, taste alteration, mucosal irritation, disruption of the commensal oral microbiome, and the potential emergence of microbial adaptation or tolerance [6]. These limitations have driven increasing interest in the development of innovative non-antibiotic therapeutic modalities capable of selectively targeting pathogenic biofilms while minimizing adverse effects on oral tissues and microbial ecology. Two promising alternative antimicrobial approaches that have emerged are cold atmospheric plasma (CAP) and antimicrobial photodynamic therapy (aPDT) [7]. Cold atmospheric plasma (CAP) was specifically selected in the present study because it represents one of the most promising emerging non-thermal antimicrobial technologies in dentistry. CAP consists of a partially ionized gas generated at near-ambient temperatures and contains a complex mixture of reactive oxygen and nitrogen species (RONS), charged particles, UV photons, and transient electric fields. Its antimicrobial activity is multifactorial, primarily mediated through oxidative damage to microbial membranes, proteins, nucleic acids, and the extracellular biofilm matrix, ultimately leading to bacterial cell death and biofilm disruption irrespective of conventional resistance mechanisms. In addition to its direct bactericidal effects, CAP has demonstrated the ability to degrade extracellular polymeric substances, reduce microbial adhesion, and suppress the acidogenic activity of cariogenic bacteria. These unique properties make CAP particularly attractive for the management of biofilm-mediated oral diseases, especially in situations where conventional antimicrobial agents may exhibit limited biofilm penetration, undesirable adverse effects, or reduced long-term effectiveness [8]. Conversely, aPDT is a light-activated modality utilizing a photosensitizing agent (e.g., methylene blue, MB) excited by light of a specific wavelength (e.g., 660 nm). This photoexcitation triggers the generation of cytotoxic reactive oxygen species (predominantly singlet oxygen), inducing rapid, targeted oxidative lethality within the illuminated field and enabling precise spatial control [9]. Both modalities present compelling advantages for dental applications: broad-spectrum activity, a low propensity for engendering microbial resistance due to their multi-targeted physical/chemical mechanisms, and potential for selective biofilm targeting [10, 11]. Despite accumulating in vitro evidence supporting the individual efficacy of CAP and aPDT against various oral pathogens [12–14], a direct and systematic comparative analysis of these two physical modalities against biofilms of S. mutans—the quintessential cariogenic pathogen—remains insufficiently explored in the literature. Prevailing investigations often assess each technology in isolation or employ planktonic cultures, models that fail to recapitulate the enhanced antimicrobial recalcitrance characteristic of the biofilm phenotype [15]. A rigorous, side-by-side evaluation of their antibiofilm performance against standardized, mature S. mutans biofilms is therefore essential. Such a comparison is pivotal for elucidating their relative efficacies, potential synergies, and translational feasibility, thereby informing the development of optimized, non-invasive clinical strategies against biofilm-mediated dental diseases [7, 16, 17]. This study aims to systematically compare the antimicrobial and biofilm-disrupting efficacy of CAP and MB-aPDT with a 660 nm laser against mature S. mutans biofilms. We hypothesize that: (i) both CAP and MB-aPDT will significantly reduce the viability and structural integrity of S. mutans biofilms compared to an untreated control; and (ii) a statistically significant difference will exist in the efficacy profile between the two treatment modalities, with one demonstrating superior biofilm eradication or disruption capacity under the defined experimental parameters. Materials and methods Sample size calculation The sample size was determined based on the study by Garcia et al. [18] using one-way ANOVA power analysis performed with SPSS software (version 11, IBM, USA). Considering an alpha error of 0.05, a beta error of 0.2 (power = 80%), a standard deviation of 0.72 for the mean log colony-forming units (CFU) count, and an effect size of 0.46, the minimum required sample size was calculated as 10 specimens per group. A total of 9 experimental groups were included in this study (n = 10 per group). Bacterial strain and culture conditions Streptococcus mutans ATCC 35,668 was obtained from the Iranian Biological Resource Center (Tehran, Iran). The lyophilized bacteria were reconstituted according to the manufacturer’s instructions and cultured on Mitis Salivarius agar (Merck, Germany) supplemented 1% sucrose (w/v). The plates were incubated under capnophilic conditions (5% CO₂) at 37 °C for 48 h to obtain isolated colonies. For preparation of bacterial suspensions, colonies were inoculated into Brain Heart Infusion (BHI) broth (Merck, Germany) and incubated at 37 °C under 5% CO₂ until reaching the logarithmic growth phase. The optical density was adjusted spectrophotometrically (BioTek Instruments, USA) at 600 nm to achieve a suspension equivalent to 0.5 McFarland standard (approximately 1.5 × 10⁸ CFU/mL). The final cell concentration was confirmed by serial dilution and colony counting on BHI agar (Merck, Germany) plates. Enamel slab preparation Human premolar teeth extracted for orthodontic purposes were collected and stored in 0.1% thymol solution at 4 °C until use. Teeth with visible cracks, caries, enamel hypoplasia, or white spot lesions on buccal or lingual surfaces were excluded. Enamel slabs measuring 3 × 3 × 1 mm were prepared from the buccal and lingual surfaces using a water-cooled diamond saw (Isomet, Buehler, USA) [19]. The outer enamel surface was polished with 600-, 800-, and 1200-grit silicon carbide papers under water irrigation to remove approximately 100 μm of the outermost enamel layer, creating a standardized flat surface [19]. The slabs were ultrasonically cleaned in distilled water for 10 min to remove debris and then sterilized by exposure to 40 kGray Gamma irradiation. Biofilm formation on enamel sabs Saliva collection and preparation Unstimulated whole saliva was collected from healthy volunteers who had no active caries, periodontal disease, or systemic diseases, and had not taken antibiotics within the preceding 3 months. The collected saliva was centrifuged at 10,000 × g for 10 min at 4 °C, filter-sterilized through a 0.22 μm membrane filter, and stored at -20 °C until use. Biofilm development S. mutans biofilms were formed on enamel slabs following the protocol described by Pourhajibagher and Bahador [20] with modifications. Sterile enamel slabs were placed in 96-well microtiter plates containing 200 µL of bacterial suspension (1.5 × 10⁸ CFU/mL) in BHI broth supplemented with 1% sucrose (w/v) and 50% filter-sterilized human saliva. The plates were incubated at 37 °C under 5% CO₂ on a shaking incubator for 7 days to allow mature biofilm formation. The culture medium was replaced every 48 h with fresh BHI broth containing 1% sucrose, and biofilms were treated with 10% sucrose for 3 min daily to promote extracellular polysaccharide production [20]. Experimental groups The enamel slabs containing S. mutans biofilms were randomly allocated into ten experimental groups (n = 10 per group) as follows: Group 1 (Negative control): Biofilms were treated with sterile physiological saline solution in culture medium without S. mutans.Group 2 (Positive control): Biofilms were treated with 0.02% chlorhexidine (Plastrin, Iran) for 1 min.Group 3 (Laser only): Biofilms were irradiated without a photosensitizer with a 660 nm continuous-wave diode laser (Sirona, Germany) at 100 mW power output, an irradiance of 0.20 W/cm², and an energy density of 20 J/cm² for 100 s. The laser beam, with a spot diameter of 8 mm, was delivered perpendicularly to the enamel surface from a standardized non-contact distance of 1 cm. This configuration ensured complete coverage of the enamel slab surface, promoted homogeneous energy distribution across the biofilm area, and minimized the risk of localized thermal accumulation or uneven irradiation during photodynamic treatment. The laser output power was verified before each experimental session using a calibrated laser power meter (Laser Point srl, Milano, Italy).Group 4 (Photosensitizer only): Biofilms were treated with 0.02% MB (Merck, Germany) dissolved in sterile distilled water for 5 min in the dark without laser irradiation.Group 5 (aPDT): Biofilms were incubated with 0.02% MB for 5 min pre-irradiation time, followed by irradiation with a 660 nm diode laser, similar to group 3.Groups 6–9 (CAP): Biofilms were treated with CAP for different exposure durations: 90, 120, 150, and 180 s. CAP was generated using a helium-based plasma jet system (PlasmArt, Nariatech, Tehran, Iran). The device operated with helium as the working gas at an inlet pressure of 4.5 bar, while the handpiece outlet pressure was maintained at atmospheric pressure. A transistor regulated the voltage to 10 kV (peak-to-peak) with an operating frequency of 100 kHz and power output of 8 W. The gas flow rate was adjusted to number 3 (3.8 L/min) and intensity of 4 (0.780 KV) using a precision low-pressure manometer to monitor the outlet gas pressure. The plasma plume length measured 21 mm with a diameter of 2.5 mm at the nozzle exit. Group 1 (Negative control): Biofilms were treated with sterile physiological saline solution in culture medium without S. mutans. Group 1 (Negative control): Biofilms were treated with sterile physiological saline solution in culture medium without S. mutans. Group 2 (Positive control): Biofilms were treated with 0.02% chlorhexidine (Plastrin, Iran) for 1 min. Group 2 (Positive control): Biofilms were treated with 0.02% chlorhexidine (Plastrin, Iran) for 1 min. Group 3 (Laser only): Biofilms were irradiated without a photosensitizer with a 660 nm continuous-wave diode laser (Sirona, Germany) at 100 mW power output, an irradiance of 0.20 W/cm², and an energy density of 20 J/cm² for 100 s. The laser beam, with a spot diameter of 8 mm, was delivered perpendicularly to the enamel surface from a standardized non-contact distance of 1 cm. This configuration ensured complete coverage of the enamel slab surface, promoted homogeneous energy distribution across the biofilm area, and minimized the risk of localized thermal accumulation or uneven irradiation during photodynamic treatment. The laser output power was verified before each experimental session using a calibrated laser power meter (Laser Point srl, Milano, Italy). Group 3 (Laser only): Biofilms were irradiated without a photosensitizer with a 660 nm continuous-wave diode laser (Sirona, Germany) at 100 mW power output, an irradiance of 0.20 W/cm², and an energy density of 20 J/cm² for 100 s. The laser beam, with a spot diameter of 8 mm, was delivered perpendicularly to the enamel surface from a standardized non-contact distance of 1 cm. This configuration ensured complete coverage of the enamel slab surface, promoted homogeneous energy distribution across the biofilm area, and minimized the risk of localized thermal accumulation or uneven irradiation during photodynamic treatment. The laser output power was verified before each experimental session using a calibrated laser power meter (Laser Point srl, Milano, Italy). Group 4 (Photosensitizer only): Biofilms were treated with 0.02% MB (Merck, Germany) dissolved in sterile distilled water for 5 min in the dark without laser irradiation. Group 4 (Photosensitizer only): Biofilms were treated with 0.02% MB (Merck, Germany) dissolved in sterile distilled water for 5 min in the dark without laser irradiation. Group 5 (aPDT): Biofilms were incubated with 0.02% MB for 5 min pre-irradiation time, followed by irradiation with a 660 nm diode laser, similar to group 3. Group 5 (aPDT): Biofilms were incubated with 0.02% MB for 5 min pre-irradiation time, followed by irradiation with a 660 nm diode laser, similar to group 3. Groups 6–9 (CAP): Biofilms were treated with CAP for different exposure durations: 90, 120, 150, and 180 s. CAP was generated using a helium-based plasma jet system (PlasmArt, Nariatech, Tehran, Iran). The device operated with helium as the working gas at an inlet pressure of 4.5 bar, while the handpiece outlet pressure was maintained at atmospheric pressure. A transistor regulated the voltage to 10 kV (peak-to-peak) with an operating frequency of 100 kHz and power output of 8 W. The gas flow rate was adjusted to number 3 (3.8 L/min) and intensity of 4 (0.780 KV) using a precision low-pressure manometer to monitor the outlet gas pressure. The plasma plume length measured 21 mm with a diameter of 2.5 mm at the nozzle exit. Groups 6–9 (CAP): Biofilms were treated with CAP for different exposure durations: 90, 120, 150, and 180 s. CAP was generated using a helium-based plasma jet system (PlasmArt, Nariatech, Tehran, Iran). The device operated with helium as the working gas at an inlet pressure of 4.5 bar, while the handpiece outlet pressure was maintained at atmospheric pressure. A transistor regulated the voltage to 10 kV (peak-to-peak) with an operating frequency of 100 kHz and power output of 8 W. The gas flow rate was adjusted to number 3 (3.8 L/min) and intensity of 4 (0.780 KV) using a precision low-pressure manometer to monitor the outlet gas pressure. The plasma plume length measured 21 mm with a diameter of 2.5 mm at the nozzle exit. Microbiological analysis Immediately after the treatments, the enamel slabs were transferred to sterile tubes containing 1 mL of phosphate-buffered saline (PBS, pH 7.4). The biofilms were detached by vortexing for 30 s. Serial 10‑fold dilutions were prepared in PBS, and 100 µL aliquots were plated on BHI agar. The plates were incubated under capnophilic conditions at 37 °C for 48 h, after which the number of CFU/mL was determined [20]. Scanning electron microscopy (SEM) analysis To assess the effect of the experimental groups on the microbial biofilm formed on the enamel surface, three separate specimens per group were analyzed qualitatively using SEM. The specimens were fixed in 2.5% glutaraldehyde for 2 h at 4 °C, dehydrated through graded ethanol series (30%, 50%, 70%, 90%, and 100%), and dried in a critical point dryer. After gold sputter-coating, specimens were examined under a SEM (ZEISS, Germany) at 15 kV accelerating voltage. Statistical analysis Data were analyzed using SPSS software version 26 (IBM, USA). The normality of data distribution was assessed using the Shapiro-Wilk test. One-way analysis of variance (ANOVA) was used to compare mean CFU/mL counts among groups, followed by Tukey’s post-hoc test for multiple comparisons. Statistical significance was set at P < 0.05. All experiments were performed in triplicate to ensure reproducibility. Results Quantitative analysis of S. mutans biofilm viability (CFU/mL) S. mutans biofilm viability across experimental groups is presented in Fig. 1. The negative control showed the highest bacterial count (26.61 ± 1.36 × 10⁶ CFU/mL). Among treatments, 0.2% CHX exhibited the strongest antibacterial effect, reducing viability to 0.118 ± 0.012 × 10⁶ CFU/mL (99.6% reduction). aPDT (MB + 660 nm laser) also significantly reduced bacterial counts to 2.47 ± 0.34 × 10⁶ CFU/mL (90.7% reduction). Fig. 1The effects of different treatments on the cell viability of Streptococcus mutans. The treatment resulted in significant reductions compared to the untreated control group (*P < 0.05) The effects of different treatments on the cell viability of Streptococcus mutans. The treatment resulted in significant reductions compared to the untreated control group (*P < 0.05) CAP treatment demonstrated a time-dependent antibacterial effect, with mean CFU/mL progressively decreasing as exposure time increased: CAP-90 s (12.36 ± 1.06 × 10⁶), CAP-120 s (7.98 ± 0.65 × 10⁶), CAP-150 s (6.24 ± 0.46 × 10⁶), and CAP-180 s (3.45 ± 0.30 × 10⁶), corresponding to 53.5%, 70.0%, 76.5%, and 87.0% reductions, respectively. In contrast, methylene blue alone (22.60 ± 1.26 × 10⁶ CFU/mL) and laser alone (25.58 ± 1.29 × 10⁶ CFU/mL) showed minimal reductions. Statistical analysis confirmed that all treatment groups except laser alone (p = 0.204) differed significantly from the control (P < 0.001). Post hoc analysis (Tukey HSD) comparing aPDT with CAP treatments (Fig. 1) revealed that aPDT was significantly more effective than CAP-90 s, CAP-120 s, and CAP-150 s, with mean differences of 9.89, 5.51, and 3.77 × 10⁶ CFU/mL, respectively (all P < 0.001). However, no significant difference was observed between aPDT and CAP-180 s (mean difference: 0.98 × 10⁶ CFU/mL; P = 0.266; 95% CI: -2.24 to 0.29 × 10⁶ CFU/mL). These findings indicate that while aPDT is superior to shorter CAP exposures, prolonged CAP treatment (180 s) achieves comparable antibacterial efficacy to aPDT. Additionally, a comparison of the colonies grown on the culture medium across the different treatment groups is presented in Fig. 2. Fig. 2Colonies of Streptococcus mutans grown on brain heart infusion (BHI) agar enriched with 1% sucrose following different treatments: (a) Negative control, (b) 0.2% chlorhexidine (CHX), (c) Laser only (660 nm), (d) 0.02% Methylene blue (MB) only, (e) Antimicrobial photodynamic therapy (aPDT; MB + 660 nm laser), (f) Cold atmospheric plasma (CAP) with an exposure duration of 90 s, (g) CAP with an exposure duration of 120 s, (h) CAP with an exposure duration of 150 s, and (i) CAP with an exposure duration of 180 s Colonies of Streptococcus mutans grown on brain heart infusion (BHI) agar enriched with 1% sucrose following different treatments: (a) Negative control, (b) 0.2% chlorhexidine (CHX), (c) Laser only (660 nm), (d) 0.02% Methylene blue (MB) only, (e) Antimicrobial photodynamic therapy (aPDT; MB + 660 nm laser), (f) Cold atmospheric plasma (CAP) with an exposure duration of 90 s, (g) CAP with an exposure duration of 120 s, (h) CAP with an exposure duration of 150 s, and (i) CAP with an exposure duration of 180 s Qualitative analysis of S. mutans biofilm viability (SEM) The SEM images (Fig. 3) demonstrate distinct differences in S. mutans biofilm architecture following various treatments, in agreement with the quantitative CFU/mL findings. In the negative control group (a), a dense and well-organized biofilm structure is evident, corresponding to the highest bacterial counts. Treatment with 0.2% CHX (b) results in a markedly disrupted biofilm with sparse bacterial aggregation, indicating the strongest antimicrobial effect among the tested groups. The laser-only irradiation at 660 nm (c) exhibits a biofilm structure comparable to the control group, suggesting a negligible antibacterial impact. Similarly, the MB-only treatment (d) shows no apparent structural disruption, with biofilm morphology resembling that of the untreated control. In contrast, aPDT (e) produces a pronounced reduction in biofilm density and structural integrity, demonstrating substantial antimicrobial activity. For CAP treatments, a time-dependent decrease in biofilm density is observed. CAP applied for 90 s (f) shows partial disruption of the biofilm structure. Increasing the exposure time to 120 s (g) results in further architectural breakdown and reduced bacterial clustering. At 150 s (h), the biofilm appears more dispersed with fewer intact microcolonies. The 180-s exposure (i) leads to marked structural disintegration and minimal residual biofilm formation. Comparatively, aPDT exhibits greater biofilm disruption than CAP at shorter exposure times (90–150 s), while demonstrating comparable efficacy to CAP applied for 180 s. Fig. 3Scanning electron microscopy (SEM) images of Streptococcus mutans biofilms on enamel slabs following different treatments: (a) Negative control, (b) 0.2% chlorhexidine (CHX), (c) Laser only (660 nm), (d) 0.02% Methylene blue (MB) only, (e) Antimicrobial photodynamic therapy (aPDT; MB + 660 nm laser), (f) Cold atmospheric plasma (CAP) with an exposure duration of 90 s, (g) CAP with an exposure duration of 120 s, (h) CAP with an exposure duration of 150 s, and (i) CAP with an exposure duration of 180 s Scanning electron microscopy (SEM) images of Streptococcus mutans biofilms on enamel slabs following different treatments: (a) Negative control, (b) 0.2% chlorhexidine (CHX), (c) Laser only (660 nm), (d) 0.02% Methylene blue (MB) only, (e) Antimicrobial photodynamic therapy (aPDT; MB + 660 nm laser), (f) Cold atmospheric plasma (CAP) with an exposure duration of 90 s, (g) CAP with an exposure duration of 120 s, (h) CAP with an exposure duration of 150 s, and (i) CAP with an exposure duration of 180 s Discussion The present study provides a direct comparative evaluation of CAP and MB-mediated aPDT against mature S. mutans biofilms formed on human enamel slabs. The findings confirm our first hypothesis that both CAP and aPDT significantly reduce biofilm viability and disrupt structural integrity compared with the untreated control. Furthermore, the second hypothesis is partially supported, as aPDT demonstrated superior efficacy compared with shorter CAP exposure times (90–150 s), while CAP applied for 180 s achieved a comparable antibacterial effect. MB was selected as the photosensitizer because of its well-documented antimicrobial efficacy, strong absorption peak near 660 nm, high singlet oxygen generation efficiency, favorable water solubility, and extensive prior validation in oral aPDT studies [21]. Moreover, MB remains one of the most clinically accessible and cost-effective photosensitizers for dental applications, facilitating comparison with existing literature [6]. The significant reduction in S. mutans biofilm viability following MB-aPDT observed in the present study aligns with the growing body of evidence supporting photodynamic therapy as an effective antibiofilm strategy, though comparative analysis reveals considerable variability in reported efficacy attributable to differences in photosensitizer type, concentration, light parameters, and biofilm models [21, 22]. Nemezio et al. [21] evaluated MB-aPDT (0.01% MB, 94 J/cm²) against S. mutans biofilms and reported significant reductions in bacterial viability, although the extent of reduction varied with biofilm maturation stage and experimental conditions. Similarly, Liang et al. [22] compared MB-aPDT and hematoporphyrin monomethyl ether (HMME)-aPDT against S. mutans biofilms, demonstrating that both modalities significantly reduced CFU counts at energy densities of 30.4 J/cm², with MB-aPDT showing superior efficacy compared to HMME-aPDT, underscoring the importance of optimizing light parameters. The 90.7% reduction achieved with MB-aPDT in this study is consistent with the well-established mechanism of aPDT, which relies on the photoexcitation of a photosensitizer by light of a specific wavelength to generate cytotoxic ROS [23, 24]. Upon irradiation at 660 nm, MB undergoes transition to an excited triplet state, subsequently interacting with molecular oxygen through two primary pathways: Type I reaction involving electron transfer to produce superoxide anion, hydrogen peroxide, and hydroxyl radicals; and Type II reaction involving energy transfer to generate highly reactive singlet oxygen (¹O₂) [23]. Singlet oxygen is considered the predominant cytotoxic species mediating aPDT efficacy, with a diffusion radius of approximately 10–20 nm in biological systems, causing rapid oxidative damage to bacterial membranes and intracellular components [24]. The spatial precision of aPDT, confined to areas where both photosensitizer and light are present, offers potential for selective biofilm targeting with minimal effects on adjacent healthy tissues [23]. This targeted mechanism contrasts with the broader, non-selective oxidative action of CAP, though both approaches share the advantage of multitarget physical/chemical mechanisms that reduce the risk of inducing microbial resistance [7, 25]. The time-dependent antibiofilm effect of CAP observed in the present study—with S. mutans viability reductions progressing from 53.5% at 90 s to 87.0% at 180 s—aligns with findings from recent investigations employing various plasma sources and experimental models, and reflects the cumulative oxidative damage inflicted by reactive oxygen and nitrogen species generated during plasma exposure. Figueira et al. [26] demonstrated that a helium low-temperature plasma jet applied to multispecies cariogenic biofilms achieved greater than 2 log₁₀ reduction in viable counts at 5–7 min, with shorter exposures producing more modest effects. Although their exposure durations exceeded those tested in the present work, the progressive increase in efficacy with extended treatment time corroborates our observation of time-dependent CAP activity, with differences in log reductions potentially attributable to variations in biofilm maturity, microbial composition, or plasma source parameters [26]. Similarly, Puca et al. [27] reported that an air-based CAP soft jet applied to S. mutans biofilms for 120–180 s induced extensive cell death and reduced biofilm thickness on confocal microscopy, with longer exposure times yielding greater antimicrobial effects—a pattern paralleling the enhanced biofilm disruption observed at 150–180 s in our study and reinforcing the critical role of treatment duration in CAP efficacy. Beyond direct bactericidal activity through RONS-mediated oxidative assault on bacterial membranes, proteins, and nucleic acids, CAP may exert additional carioprotective effects through metabolic modulation. Zhao et al. [28] investigated argon-based CAP against S. mutans UA159 biofilms and reported significant antibacterial effects, with CAP demonstrating stronger antiproliferative activity than ultraviolet irradiation under comparable conditions. Importantly, their study revealed that CAP inhibits acid production by biofilms and enhances enamel acid resistance, suggesting mechanisms that extend beyond simple bacterial killing to include interference with cariogenic metabolism—findings that complement our results by indicating that CAP not only reduces bacterial viability but may also attenuate the pathogenic potential of residual biofilms [28]. Liguori et al. [29] evaluated dielectric barrier discharge plasma against S. mutans biofilms on soft reline materials, reporting that 120-s CAP exposure reduced mature biofilm viability by approximately 2 log₁₀. This efficacy exceeds the 87.0% reduction observed in our study at 180 s, which may reflect differences in plasma source configuration, substrate material, biofilm maturation protocols, or quantification methods. Nevertheless, the consistent demonstration of significant antibiofilm activity across diverse experimental systems supports CAP as a promising adjunctive technology for managing S. mutans biofilms [26–29]. In the current enamel-based model, CAP applied at 8 W with helium flow produced substantial biofilm inactivation while maintaining overall enamel surface integrity. Nevertheless, SEM observations following longer CAP exposures suggested possible mild surface morphological alterations or roughening compared with aPDT-treated specimens. Previous studies have similarly reported time-dependent enamel surface modifications after plasma exposure, potentially related to oxidative etching and physicochemical interactions between reactive plasma species and hydroxyapatite surfaces. Therefore, although severe destructive changes were not observed in the present study, the possibility of subtle enamel surface alteration after prolonged CAP exposure should be carefully considered when optimizing clinical treatment parameters. Variability across CAP studies—including differences in single-species versus multispecies biofilms, biofilm age, plasma physics, and application protocols—helps explain variations in reported log reductions [26, 27, 29]. A systematic review and meta-analysis by Sanesi et al. [25] confirmed the antimicrobial effect of direct CAP application against oral pathogens, reporting a pooled standardized mean difference of 4.51 for Enterococcus faecalis reduction, while highlighting considerable heterogeneity across studies regarding treatment parameters, gas composition, and clinical application protocols. Despite methodological differences, the convergent evidence from these investigations reinforces the potential of CAP as a versatile antimicrobial approach for challenging dental applications where mechanical debridement may be insufficient, such as deep fissures, dentinal tubules, periodontal pockets, and implant surfaces [25–29]. Yeganehfard et al. [7] recently conducted a direct comparative investigation of PDT at two wavelengths (660 nm with MB and 810 nm with indocyanine green) alongside CAP treatment (90–180 s) against S. mutans. Their findings closely parallel our results, demonstrating that CAP-180 s achieved substantial bacterial reduction (36.75 ± 18.87 CFU) comparable to PDT 660 nm + MB (39.25 ± 5.62 CFU), with no statistically significant difference between these modalities. Interestingly, their study revealed that PDT 810 nm + ICG showed numerically lower CFU counts (23.5 ± 11.67 CFU) than both CAP-180 s and MB-aPDT, suggesting that near-infrared wavelengths with ICG may offer enhanced efficacy for certain applications [7]. This aligns with our observation that both physical modalities achieve significant antibiofilm effects, while also highlighting the potential for optimizing photosensitizer-light combinations to maximize therapeutic outcomes. Within restorative and preventive dentistry, CAP and MB-aPDT could be integrated into minimally invasive caries management to disinfect demineralized pits and fissures or residual carious dentin prior to sealing or restoration, potentially reducing residual S. mutans loads and secondary caries risk [30, 31]. From an economic and translational perspective, CAP systems currently require higher initial equipment investment compared with conventional antiseptic approaches. Nevertheless, CAP does not require exogenous photosensitizers or disposable antimicrobial agents, potentially reducing long-term consumable costs. Moreover, the multifunctional applicability of CAP in dentistry—including biofilm decontamination, implant surface disinfection, wound healing support, and endodontic applications—may improve overall cost-efficiency in specialized clinical environments. The broad-spectrum antimicrobial activity of CAP, combined with its low likelihood of inducing microbial resistance, further supports its potential long-term clinical value. However, additional clinical and health-economic studies are still required to determine the cost-effectiveness of CAP in routine dental practice [8, 11]. In orthodontics, adjunctive aPDT around brackets and bands may help control biofilm accumulation in patients with suboptimal hygiene, offering an alternative to repeated CHX use and mitigating bracket-associated white spot lesions [20, 32]. For high-risk or medically compromised patients, targeted applications on root surfaces, around restoration margins, or in fissures could be scheduled at recall visits as part of personalized caries risk–management protocols, complementing fluoride, dietary counseling, and mechanical plaque control [33, 34]. Given the comparable efficacy of MB-aPDT and longer CAP exposures in the present work, device-level considerations become important: CAP systems may be particularly attractive in clinical environments already using plasma tools for soft tissue or wound applications [35], whereas MB-aPDT may be easier to adopt in practices equipped with diode lasers and familiar with laser safety [25]. Future development of combined or sequential protocols—for example, MB-aPDT followed by short CAP exposure—could theoretically exploit complementary mechanisms to maximize biofilm eradication while keeping individual doses within safe and practical limits, although such combinatorial strategies require rigorous experimental validation [36, 37]. Beyond antimicrobial efficacy, the biological safety and host-tissue compatibility of these emerging therapeutic modalities are equally important for their successful clinical translation [8, 11]. Previous studies have demonstrated that appropriately optimized CAP protocols generally exhibit acceptable cytocompatibility toward gingival fibroblasts, oral keratinocytes, and other mammalian oral cells, while in some cases promoting wound healing and tissue regeneration through controlled redox signaling [8, 11, 12]. However, excessive plasma exposure duration or high concentrations of reactive species may induce oxidative stress, mitochondrial dysfunction, DNA damage, or apoptosis in host tissues [8, 12]. Similarly, methylene blue-mediated aPDT has shown favorable biocompatibility because reactive oxygen species generation remains localized to irradiated photosensitizer-containing areas [6, 38]. Nevertheless, high photosensitizer concentrations or excessive light fluence may negatively affect host-cell viability [6]. Therefore, optimization of treatment parameters remains essential to maximize antimicrobial efficacy while preserving the integrity and viability of surrounding oral tissues [6, 11, 38]. Several limitations of this study should be acknowledged. This investigation employed a monospecies S. mutans biofilm on standardized flat enamel slabs. While this model offers a controlled and clinically relevant platform for initial efficacy assessment, it does not fully replicate the complexity of multispecies, saliva-bathed plaque in vivo, which involves dynamic nutrient flow and host-derived factors. Additionally, only a single MB concentration, one irradiation parameter set, and one CAP configuration were tested; therefore, the findings may not be directly extrapolated to other photosensitizer doses, light fluences, plasma sources, or clinical geometries. Future investigations should evaluate CAP and MB-aPDT against mature multispecies biofilms in dynamic models, optimize dosing regimens for shorter chairside application, and assess their effects on enamel and dentin, pulp safety, and the balance between pathogenic and commensal flora. Randomized clinical trials in high-caries-risk and orthodontic populations will be essential to determine whether the substantial in vitro/ex vivo reductions observed translate into meaningful decreases in lesion incidence and progression. Conclusion We conclude that both helium‑based CAP and MB‑aPDT at 660 nm significantly reduced S. mutans biofilm viability and disrupted biofilm structure, with 0.2% CHX remaining the most potent modality and CAP‑180 s achieving antibacterial effects comparable to MB‑aPDT. These findings support the clinical potential of these non‑antibiotic physical approaches as adjuncts to mechanical biofilm control and conventional chemotherapeutics in caries‑preventive and restorative dentistry.